Lung EpiCheck Biomarkers Development Study
NCT06245876 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2024-02-12
Summary
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Conditions
Interventions
- OTHER
-
Blood collection
Blood collection
Sponsors & Collaborators
-
Nucleix Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-17
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
- Hungary
- Israel
- Netherlands
Study Locations
More Related Trials
-
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769 ·Status: RECRUITING ·Phase: NA
-
'Lung Health Check' Biomarker Study
NCT04957433 ·Status: UNKNOWN
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Study for Lung Cancer Detection Test
NCT01700452 ·Status: COMPLETED
-
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638 ·Status: COMPLETED
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
NCT00899262 ·Status: UNKNOWN
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Pilot Study of High Risk Lung Cancer Screening
NCT03683940 ·Status: COMPLETED ·Phase: NA
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
NCT01700257 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DNA Chip Based Prognosis of Lung Cancer
NCT00973427 ·Status: COMPLETED
-
Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)
NCT06193239 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
NCT04817046 ·Status: UNKNOWN
-
Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT01663155 ·Status: COMPLETED
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
NCT03499678 ·Status: TERMINATED
-
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
NCT00897364 ·Status: COMPLETED